Priority Date: 11.09.09 (US 20090241527P)

N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridin yl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine for use in the treatment of antimitotic agent resistant cancer

  • Application ID: EP14186203
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 201 - 500 employees
Company dna grunecker kinkeldey stockmair and schwanhausser
operating since 1924
Headquarter in Munich and 2 offices
active in Legal Services

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 11.09.2009 - Priority Date (US 20090241527P)
  • 31.12.2014 - Publication A1 (EP2818170)

IPC Classification